Biogen Raises 2026 Adjusted EPS Floor by 20 Cents
Biogen raised the lower end of its 2026 adjusted EPS guidance by 20 cents. Rare-disease revenue increased 27%.
Site Search
Search market news
Find public news by keyword, exact ticker, category and date.
Matching instruments
Open a ticker page for its news coverage. The news search below stays a text search.